Skip to content

The impact of the COVID-19 pandemic on the provision, practice, and outcomes of vascular surgery (COVER study)

The impact of the COVID-19 pandemic on the provision, practice, and outcomes of vascular surgery. An international cohort study (COVER)

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ISRCTN
Registry ID
ISRCTN80453162
Enrollment
200
Registered
2020-04-14
Start date
2020-04-09
Completion date
Unknown
Last updated
2022-03-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Any vascular condition, including: aortic or other type of aneurysmal disease, peripheral arterial disease, venous disease, vascular malformations, trauma, major haemorrhage, access (for renal dialysis), carotid (and cerebrovascular) disease, any other type of pathology treated by vascular surgeons. Circulatory System

Interventions

This project is a three-tiered study designed to fully elucidate the impact of the COVID-19 pandemic on vascular surgery across the world. The aim of Tier 1 is to document how the pro
Tier 2: procedures performed in each centre
Tier 3: assessment of longer-term outcomes. Time – end of study 12 months after the end of the COVID19 pandemic. The study is formally supported by the Vascular Societ

Sponsors

University Hospitals Coventry and Warwickshire NHS Trust
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Any patient with a vascular condition

Exclusion criteria

Exclusion criteria: Does not meet inclusion criteria

Design outcomes

Primary

MeasureTime frame
1. Structure and processes within the vascular service measured using a novel online questionnaire weekly until the end of data collection 2. Document all vascular surgery and interventional procedures performed using an online purpose-built data collection tool (per centre/patient) at baseline, time/date of surgery, date of discharge from hospital, three, six, and twelve months: 2.1. Type of procedure performed 2.2. Time taken from presentation to the surgical team to intervention 2.3. Mode of referral (primary vs. secondary care) 2.4. Site of surgery – hub or spoke hospital 2.5. Imaging modalities used and timings 2.6. Emergency classification i.e. urgent/emergency/elective 2.7. Operative technique(s) and device(s) used 2.8. Mode(s) of anaesthesia (local, regional, general, locoregional, other) 2.9. Whether suspected or confirmed COVID-19 positive (+ve) at time of surgery, COVID-19 +ve after surgery, or COVID-19 negative (-ve) 2.10. Documentation of changes to usual practice for this specific procedure as per surgeon’s standard protocol (type of procedure, type of anaesthetic, post-procedural destination) 3. Management of all referred urgent vascular cases using the online survey, focusing on: 3.1. Chronic Limb Threatening Ischaemia (CLTI): 3.1.1. Decision to discharge/admit/refer to a "hot"/emergency clinic 3.1.2. Decision for endovascular or open surgery first 3.1.3. Decision for best medical therapy or palliation or primary amputation 3.2. Carotid disease: 3.2.1. Number of patients managed with best medical therapy (BMT) 3.2.2. Modifications to the indication and decision for carotid endarterectomy (CEA) 3.2.3. Delays to treatment due to lack of

Secondary

MeasureTime frame
1. Collected after surgery has been performed at three, six, and twelve months using patient records: 1.1. Re-admission 1.2. Re-intervention 1.3. All-cause mortality 1.4. Operation-specific morbidity 1.5. Morbidity 1.6. [If COVID-19 +ve] - respiratory outcome, admission to intensive care unit 2. Condition-specific outcomes at 3, 6 months and 1 year: 2.1. CLTI - limb salvage, amputation free survival, all-cause mortality 2.2. Carotid disease - ipsilateral stroke rate, any stroke rate, all-cause mortality 2.3. AAA - aneurysm-related mortality, all-cause mortality 2.4. AAS - complication rate including ruptures, all-cause mortality

Countries

Afghanistan, Albania, Algeria, American Samoa, Andorra, Angola, Anguilla, Antarctica, Antigua and Barbuda, Argentina, Armenia, Aruba, Australia, Austria, Azerbaijan, Bahamas, Bahrain, Bangladesh, Barbados, Belarus, Belgium, Belize, Benin, Bermuda, Bhutan, Bolivia, Bonaire Saint Eustatius and Saba, Bosnia and Herzegovina, Botswana, Bouvet Island, Brazil, British Indian Ocean Territory, Brunei, Bulgaria, Burkina Faso, Burundi, Cambodia, Cameroon, Canada, Cape Verde, Cayman Islands, Central African Republic, Chad, Chile, China, Christmas Island, Cocos (Keeling) Islands, Colombia, Comoros, Congo, Congo, Democratic Republic, Cook Islands, Costa Rica, Cote d'Ivoire, Croatia, Cuba, Curacao, Cyprus, Czech Republic, Denmark, Djibouti, Dominica, Dominican Republic, Ecuador, Egypt, El Salvador, England, Equatorial Guinea, Eritrea, Estonia, Ethiopia, Falkland Islands, Faroe Islands, Fiji, Finland, France, French Guiana, French Polynesia, French Southern Territories, Gabon, Gambia, Georgia, Germany, Ghana, Gibraltar, Greece, Greenland, Grenada, Guadeloupe, Guam, Guatemala, Guernsey, Guinea, Guinea-Bissau, Guyana, Haiti, Heard Island and Mcdonald Islands, Holy See (Vatican City State), Honduras, Hong Kong, Hungary, Iceland, India, Indonesia, Iran, Iraq, Ireland, Isle of Man, Israel, Italy, Jamaica, Japan, Jersey, Jordan, Kazakhstan, Kenya, Kiribati, Korea, North, Korea, South, Kosovo, Kuwait, Kyrgyzstan, Laos, Latvia, Lebanon, Lesotho, Liberia, Libya, Liechtenstein, Lithuania, Luxembourg, Macao, Macedonia, Madagascar, Malawi, Malaysia, Maldives, Mali, Malta, Marshall Islands, Martinique, Mauritania, Mauritius, Mayotte, Mexico, Micronesia, Federated States of, Moldova, Monaco, Mongolia, Montenegro, Montserrat, Morocco, Mozambique, Myanmar, Namibia, Nauru, Nepal, Netherlands, Netherlands Antilles, New Caledonia, New Zealand, Nicaragua, Niger, Nigeria, Niue, Norfolk Island, Northern Mariana Islands, Norway, Oman, Pakistan, Palau, Palestinian Territory, Panama, Papua New Guinea, Paraguay, Peru, Philippines, Pitcairn, Poland, Portugal, Puerto Rico, Qatar, Reunion, Romania, Russian Federation, Rwanda, Saint Barthelemy, Saint Helena, Saint Kitts and Nevis, Saint Lucia, Saint Martin (French part), Saint Pierre and Miquelon, Saint Vincent and the Grenadines, Samoa, San Marino, Sao Tome and Principe, Saudi Arabia, Senegal, Serbia, Seychelles, Sierra Leone, Singapore, Sint Maarten (Dutch part), Slovakia, Slovenia, Solomon Islands, Somalia, South Africa, South Georgia and the South Sandwich Is, South Sudan, Spain, Sri Lanka, Sudan, Suriname, Svalbard and Jan Mayen, Swaziland, Sweden, Switzerland, Syria, Taiwan, Tajikistan, Tanzania, Thailand, Timor-Leste, Togo, Tokelau, Tonga, Trinidad and Tobago, Tunisia, Turkey, Turkmenistan, Turks and Caicos Islands, Tuvalu, Uganda, Ukraine, United Arab Emirates, United Kingdom, United States Minor Outlying Islands, United States of America, Uruguay, Uzbekistan, Vanuatu, Venezuela, Viet Nam, Virgin Islands, British, Virgin Islands, U.S., Wallis and Futuna, Western Sahara, Yemen, Zambia, Zimbabwe

Contacts

Public ContactRuth;Sandip Benson;Nandhra

;

vern.arterial.disease@gmail.com;vern.arterial.disease@gmail.com+44 (0)121 4143344;+44 (0)191 2336161

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026